Ignite Creation Date:
2024-05-05 @ 10:32 PM
Last Modification Date:
2024-10-26 @ 10:20 AM
Study NCT ID:
NCT01125800
Status:
COMPLETED
Last Update Posted:
2017-03-20
First Post:
2010-05-12
Brief Title:
A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Astrocytoma |
| Medulloblastoma |
| Rhabdomyosarcoma |
| Neuroblastoma |
| Hepatoblastoma |
| Glioma |